Methylphenidate Film, Extended Release shortage
Methylphenidate Film, Extended Release is currently listed in shortage by the FDA. The FDA lists 4 affected products. This page was last refreshed from FDA data on Oct 1, 2026.
Methylphenidate extended-release film has been on the FDA shortage list for over a year, though all strengths (10 mg, 15 mg, 20 mg, and 30 mg) still have at least one supply source. Methylphenidate patches in multiple strengths are listed by makers not reporting a shortage.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Methylphenidate Film, Extended Release. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 2, 2026Currently in shortage4 of 4 products affected.
-
Feb 28, 2025First reported to the FDA4 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Noven Pharmaceuticals, Inc. 📞 800-455-8070 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65) | — | Available | Distributed by Padagis US LLC | — |
| Current | Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65) | — | Available | Distributed by Padagis US LLC | — |
| Current | Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65) | — | Available | Distributed by Padagis US LLC | — |
| Current | Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65) | — | Available | Distributed by Padagis US LLC | — |
These rows are manufacturer reports to the FDA for Methylphenidate Film, Extended Release — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Methylphenidate Film, Extended Release? options further down this page.
Why is Methylphenidate Film, Extended Release in shortage?
It looks like all four strengths of this methylphenidate extended-release film from Noven Pharmaceuticals — the 10 mg, 15 mg, 20 mg, and 30 mg — are currently listed as available, and all are distributed by Padagis US LLC. The FDA hasn't shared a specific reason for why this product appears on the shortage list, and Noven/Padagis didn't provide any additional public explanation either.
Since no reason was given, I honestly can't tell you what originally triggered the shortage listing. What I can say is that, based on this report, all four strengths from this manufacturer are showing as available right now. Keep in mind this report only reflects what Noven Pharmaceuticals filed with the FDA — other manufacturers may also make versions of this medication.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Methylphenidate Film, Extended Release, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Methylphenidate Film, Extended Release?
Methylphenidate extended-release film is currently on the FDA shortage list. If you or someone in your care takes this medicine, I want you to know that every strength still has a reported source of supply right now.
All four strengths — 10 mg, 15 mg, 20 mg, and 30 mg — are listed as available through the distributor, Padagis US LLC. None of these strengths are reported as having no source at this time. This record reflects one manufacturer, and the shortage has lasted over a year, so you may still see uneven stock from one pharmacy to the next. No recovery date is given in the data.
Here are the steps I would take:
- Do not stop, skip, or change your dose on your own.
- Because your strength still has supply, ask your pharmacy to order it — they can check their wholesaler and the manufacturer.
- The same medicine (methylphenidate) is also made as a skin patch by other makers; your pharmacy may be able to source one of those, though it may not be in local stock. Any change like this should be decided with your prescriber.
- If your exact film strength cannot be found, ask your pharmacist or prescriber about options.
Manufacturer contact numbers are listed on this page for reference, though pharmacies usually make these calls. Local stock can differ from this national data.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
- This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Methylphenidate Film, Extended Release?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Methylphenidate Film, Extended Release is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Methylphenidate | METHYLPHENIDATE 1.1 mg/h | Patch · Transdermal | Mylan Pharmaceuticals Inc. | 00378-8260-93 |
| Methylphenidate | METHYLPHENIDATE 1.6 mg/h | Patch · Transdermal | Mylan Pharmaceuticals Inc. | 00378-8261-93 |
| Methylphenidate | METHYLPHENIDATE 2.2 mg/h | Patch · Transdermal | Mylan Pharmaceuticals Inc. | 00378-8262-93 |
| Methylphenidate | METHYLPHENIDATE 3.3 mg/h | Patch · Transdermal | Mylan Pharmaceuticals Inc. | 00378-8263-93 |
| Daytrana | METHYLPHENIDATE 10 mg/9h | Patch · Transdermal | Noven Therapeutics, LLC | 68968-5552-03 |
| Daytrana | METHYLPHENIDATE 15 mg/9h | Patch · Transdermal | Noven Therapeutics, LLC | 68968-5553-03 |
| Daytrana | METHYLPHENIDATE 20 mg/9h | Patch · Transdermal | Noven Therapeutics, LLC | 68968-5554-03 |
| Daytrana | METHYLPHENIDATE 30 mg/9h | Patch · Transdermal | Noven Therapeutics, LLC | 68968-5555-03 |
Alternative dosage forms of Methylphenidate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 9 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Daytrana 15 mg/9h | Noven | 30 patches | $5.744 | AB | Availability likely |
| Daytrana 30 mg/9h | Noven | 30 patches | $5.767 | AB | Availability likely |
| Daytrana 10 mg/9h | Noven | 30 patches | $5.787 | AB | Availability likely |
| Methylphenidate 1.6 mg/h | Mylan | 30 patches | $6.633 | AB | Availability likely |
| Methylphenidate Transdermal System 41.3 mg/mg | PADAGIS | 30 patches | $6.633 | AB | Availability likely |
| Methylphenidate 1.1 mg/h | Mylan | 30 patches | $6.664 | AB | Availability likely |
| Methylphenidate Transdermal System 27.5 mg/mg | PADAGIS | 30 patches | $6.664 | AB | Availability likely |
| Methylphenidate 3.3 mg/h | Mylan | 30 patches | $7.253 | AB | Availability likely |
| Methylphenidate Transdermal System 82.5 mg/mg | PADAGIS | 30 patches | $7.253 | AB | Availability likely |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Methylphenidate Film, Extended Release — that fall in the same broad treatment class (tx for attention deficit-hyperact(adhd)/narcolepsy) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other psychiatry shortages
Methylphenidate Film, Extended Release shortage FAQs
Is Methylphenidate Film, Extended Release in shortage?
Which products are affected?
When will Methylphenidate Film, Extended Release be available again?
Can I still get Methylphenidate somewhere?
What should I do if I take Methylphenidate Film, Extended Release?
Still have a question about the Methylphenidate Film, Extended Release shortage?
Ask a pharmacist about this shortage →View Methylphenidate Film, Extended Release on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.